Investors – investment in the future of formulation and drug delivery

InnoCore Pharmaceuticals’ is a private company with investors from industry and academia.

We are an established, revenue-generating company with a proven track record of 20+ years, with first mover advantage with our unique polymeric drug delivery platform, SynBiosys®.

Combined with its ambitious growth strategy, InnoCore is in a strong position, with a leadership team that has deep expertise across formulation, drug delivery development, project management and business development.

Investment case
Innovating peptide and biologic drug formulation & delivery
Next generation scalable, tunable Long-acting Injectable (LAI) dosage forms
Proprietary polymeric drug delivery platform, SynBiosys®
Spanning early PoC to clinical trial usage to easy-to-scale cGMP forms
Creating LAI dosage forms with wide therapeutic applications
Flexible, expert teams working as true strategic partners to its customers
Proven track record of 20+ years of scientific excellence and expertise
Diverse customers across industry & NGOs, provide validation
Serving large and rapidly growing markets

Why invest in InnoCore?

Backed by science.
Protected by patents.

Because we unite science, technology and talent to get ahead of disease together with our partners - to deliver strong and sustainable returns as a company where our people can thrive.

Investment opportunities
We are always open to discussing our business with potential investment partners. If you are interested in supporting a company with an ambitious growth strategy and a unique offering in LAI drug delivery development of complex peptides and biologics, get in touch.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.